APP and Alzheimer disease: PSEN1 mutations increase APP processing by γ-secretase, thus increasing the production of longer, more pathogenic Aβ peptides (Sherrington et al., 1995) and have mostly commonly been used in combination with mutant APP to model aspects of AD in the mouse.